130 results on '"Berni, E."'
Search Results
2. POS1432 SHORT-TERM RISK OF OSTEOPOROSIS IN ADULTS TREATED WITH CORTICOSTEROIDS: AN OBSERVATIONAL STUDY
3. Applications of nanoparticles synthesized by yeasts: a green and eco-friendly method.
4. PGI32 Patterns of Stability and Associated Healthcare Costs for Patients with Opioid Induced Constipation: A Retrospective UK Database Analysis
5. Effect of ethanol on growth of Chrysonilia sitophila (‘the red bread mould’) and Hyphopichia burtonii (‘the chalky mould’) in sliced bread
6. Evaluation of Candida albicans adhesion and biofilm formation on a denture base acrylic resin containing silver nanoparticles
7. A multiplex RT-PCR approach to detect aflatoxigenic strains of Aspergillus flavus
8. Unilateral corneal endothelial dystrophy and anterior keratoconus
9. House-mycobiota and use of biocompetitors in a Culatello manufacturing plant
10. Inhibiting and Inactivating Effect of Chitosan on Heat Resistant Moulds Responsible for Spoilage of Pasteurized Fruit Products
11. Micobiota autoctono e uso di biocompetitori in un impianto per la produzione di Culatello
12. Patterns of Estimated Glomerular Filtration Rate and Albuminuria in Relation to Progression to Serious Outcomes: Hospitalization for Infection, Major Adverse Cardiovascular Events and Renal Failure
13. Healthcare Resource Utilisation Associated with Patients Treated with Either Exenatide Once Weekly or Basal Insulin: A Retrospective UK Database Analysis
14. PTU-114 Treatment Switching Patterns between Gaviscon Formulations and Other Alginates Prescribed for Gastroesophageal Reflux Disease (GERD) In Routine, General Practice
15. Mycotoxins Biocontrol: two examples of intra- and inter-specific biocompetition
16. Correction of secondary ametropia post penetrating keratoplasty and deep anterior lamellar keratoplasty
17. Evaluation of Candida albicans adhesion and biofilm formation on a denture base acrylic resin containing silver nanoparticles
18. Evaluation of The Cost Effectiveness of Rifaximin-Á In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Belgium
19. Evaluation of The Cost Effectiveness of Rifaximin-á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Sweden
20. Evaluation of The Cost Effectiveness and Societal Impact of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In The Netherlands
21. Cost Effectiveness of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In United Kingdom
22. P0139 : Patients experiencing repeated episodes of hepatic encephalopathy have increasing risk of death. A post HOC analysis of rifaximin-α open label study data
23. Electrochemiluminescence for differential anions sensing
24. PUK4 - Patterns of Estimated Glomerular Filtration Rate and Albuminuria in Relation to Progression to Serious Outcomes: Hospitalization for Infection, Major Adverse Cardiovascular Events and Renal Failure
25. A Dizinc Complex for Selective Fluorescence Sensing of Uridine and Uridine-Containing Dinucleotides
26. LA POLITICA DELLA VALORIZZAZIONE DELLA RICERCA UNIVERSITARIA: IL CASO P.I.S.A. SRL: UN’IMPRESA SPIN-OFF PRODUTTRICE DI PERLE
27. Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis
28. PWE-154 The First Evaluation Of The Relationship Between The Chronic Liver Disease Questionnaire And The Eq-5d Index In Hepatic Encephalopathy Patients Treated With Rifaximin-a
29. Graphene and carbon nanotube nanocomposite for gene transfection
30. Treatment Of Neuropathic Pain With The Capsaicin 8% Patch Qutenzatm: Evaluation Of Time To Retreatment, Patch Usage And Pain Alleviation
31. Difficulty in establishing the impact of drugs on quality of life in cognitively impaired patients: Example of attempting to derive utility in patients treated with rifaximin-α for the reduction of recurrence of episodes of hepatic encephalopathy
32. 'Coordination Properties of a Polyamine Cryptand with Two Different Binding Moieties. A Case of pH-Modulated Antenna Device Based on a New Eu(III) Cryptate Complex'
33. PDB34 - Healthcare Resource Utilisation Associated with Patients Treated with Either Exenatide Once Weekly or Basal Insulin: A Retrospective UK Database Analysis
34. Violacein/poly(ϵ-caprolactone)/chitosan nanoparticles against bovine mastistis: Antibacterial and ecotoxicity evaluation
35. Polyphasic approach for differentiatingPenicillium nordicumfromPenicillium verrucosum
36. Facing the problem of “false positives”: Re-assessment and improvement of a multiplex RT-PCR procedure for the diagnosis of A. flavus mycotoxin producers
37. Spontaneous in-the-Bag Intraocular Lens Luxation into the Vitreous Cavity: Last-Stage Complication of Pseudoexfoliative Syndrome after Phacoemulsification
38. PSY4 - Treatment Of Neuropathic Pain With The Capsaicin 8% Patch Qutenzatm: Evaluation Of Time To Retreatment, Patch Usage And Pain Alleviation
39. PRM8 - Difficulty in establishing the impact of drugs on quality of life in cognitively impaired patients: Example of attempting to derive utility in patients treated with rifaximin-α for the reduction of recurrence of episodes of hepatic encephalopathy
40. Polyphasic approach for differentiating Penicillium nordicum from Penicillium verrucosum.
41. Binding of nucleobases to a dizinc macrocyclic complex. Supramolecular assembling of dinuclear clusters through N-HO and C-HO hydrogen bonding
42. Complexation of Ni(II) and Co(II) with 1,4-Dioxa-7,10,13-triazacyclopentadecane (<BO>L</BO>). Crystal Structure of [NiLCl][NiL(H<INF>2</INF>O)](ClO<INF>4</INF>)<INF>3</INF> and Macrocycle-Induced Dioxygen Binding
43. PGI38 - Evaluation of The Cost Effectiveness and Societal Impact of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In The Netherlands
44. PGI35 - Evaluation of The Cost Effectiveness of Rifaximin-Á In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Belgium
45. PGI25 - Cost Effectiveness of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In United Kingdom
46. PGI21 - Evaluation of The Cost Effectiveness of Rifaximin-á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Sweden
47. Complexation of Ni(II) and Co(II) with 1,4-Dioxa-7,10,13-triazacyclopentadecane (L). Crystal Structure of [NiLCl][NiL(H2O)](ClO4)3 and Macrocycle-Induced Dioxygen Binding
48. Complexation of Ni(II) and Co(II) with 1,4-Dioxa-7,10,13-triazacyclopentadecane (L). Crystal structure of [NiLCl][NiL(H2O)](ClO4)3 and macrocycle-induced dioxygen binding
49. PGI38 Evaluation of The Cost Effectiveness and Societal Impact of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In The Netherlands
50. PGI21 Evaluation of The Cost Effectiveness of Rifaximin-á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Sweden
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.